|
US3720760A
(en)
*
|
1968-09-06 |
1973-03-13 |
Pharmacia Ab |
Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples
|
|
DE2031216A1
(de)
*
|
1969-06-19 |
1971-01-14 |
Citizen Watch Co Ltd , Tokio |
Tag und Datum Stellvorrichtung fur Uhren mit Kalender
|
|
US3940475A
(en)
*
|
1970-06-11 |
1976-02-24 |
Biological Developments, Inc. |
Radioimmune method of assaying quantitatively for a hapten
|
|
US4211771A
(en)
*
|
1971-06-01 |
1980-07-08 |
Robins Ronald K |
Treatment of human viral diseases with 1-B-D-ribofuranosyl-1,2,4-triazole-3-carboxamide
|
|
CA1049411A
(en)
*
|
1972-12-18 |
1979-02-27 |
Affiliated Medical Research |
N-substituted pyridone and general method for preparing pyridones
|
|
USRE30985E
(en)
*
|
1978-01-01 |
1982-06-29 |
|
Serum-free cell culture media
|
|
US6936694B1
(en)
*
|
1982-05-06 |
2005-08-30 |
Intermune, Inc. |
Manufacture and expression of large structural genes
|
|
US4657866A
(en)
*
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
|
US4767704A
(en)
*
|
1983-10-07 |
1988-08-30 |
Columbia University In The City Of New York |
Protein-free culture medium
|
|
US4683202A
(en)
*
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4683195A
(en)
*
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4737456A
(en)
*
|
1985-05-09 |
1988-04-12 |
Syntex (U.S.A.) Inc. |
Reducing interference in ligand-receptor binding assays
|
|
US4810643A
(en)
*
|
1985-08-23 |
1989-03-07 |
Kirin- Amgen Inc. |
Production of pluripotent granulocyte colony-stimulating factor
|
|
US4927762A
(en)
*
|
1986-04-01 |
1990-05-22 |
Cell Enterprises, Inc. |
Cell culture medium with antioxidant
|
|
US4810804A
(en)
*
|
1987-03-26 |
1989-03-07 |
Allergan, Inc. |
Acetylenes disubstituted with a phenyl group and a heterobicyclic group having retinoid-like activity
|
|
DE68906153T2
(de)
*
|
1988-02-26 |
1993-10-28 |
Genentech Inc |
Humanes relaxinpräparat.
|
|
US5270198A
(en)
*
|
1988-05-20 |
1993-12-14 |
Genentech, Inc. |
DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
|
|
US5534617A
(en)
*
|
1988-10-28 |
1996-07-09 |
Genentech, Inc. |
Human growth hormone variants having greater affinity for human growth hormone receptor at site 1
|
|
US5240848A
(en)
*
|
1988-11-21 |
1993-08-31 |
Monsanto Company |
Dna sequences encoding human vascular permeability factor having 189 amino acids
|
|
US5571714A
(en)
*
|
1988-12-22 |
1996-11-05 |
Celtrix Pharmaceuticals, Inc. |
Monoclonal antibodies which bind both transforming growth factors β1 and β2 and methods of use
|
|
US5514646A
(en)
*
|
1989-02-09 |
1996-05-07 |
Chance; Ronald E. |
Insulin analogs modified at position 29 of the B chain
|
|
US5332671A
(en)
*
|
1989-05-12 |
1994-07-26 |
Genetech, Inc. |
Production of vascular endothelial cell growth factor and DNA encoding same
|
|
CA2017379C
(en)
*
|
1989-05-24 |
2002-06-25 |
Kenneth A. Thomas, Jr. |
Purification and characterization of a glioma-derived growth factor
|
|
US5194596A
(en)
*
|
1989-07-27 |
1993-03-16 |
California Biotechnology Inc. |
Production of vascular endothelial cell growth factor
|
|
US5395760A
(en)
*
|
1989-09-05 |
1995-03-07 |
Immunex Corporation |
DNA encoding tumor necrosis factor-α and -β receptors
|
|
US5605690A
(en)
*
|
1989-09-05 |
1997-02-25 |
Immunex Corporation |
Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
|
|
US5716632A
(en)
*
|
1989-11-22 |
1998-02-10 |
Margolin; Solomon B. |
Compositions and methods for reparation and prevention of fibrotic lesions
|
|
US5310562A
(en)
*
|
1989-11-22 |
1994-05-10 |
Margolin Solomon B |
Composition and method for reparation and prevention of fibrotic lesions
|
|
US5518729A
(en)
*
|
1989-11-22 |
1996-05-21 |
Margolin; Solomon B. |
Compositions and methods for reparation and prevention of fibrotic lesions
|
|
US5726152A
(en)
*
|
1990-09-21 |
1998-03-10 |
Merck & Co., Inc. |
Vascular endothelial cell growth factor II
|
|
US5122469A
(en)
*
|
1990-10-03 |
1992-06-16 |
Genentech, Inc. |
Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
|
|
TW197439B
(https=)
*
|
1991-04-04 |
1993-01-01 |
Ueno Pharmaceutics Applic Res Co Ltd |
|
|
US5736371A
(en)
*
|
1991-06-04 |
1998-04-07 |
A Et S Biovecteurs |
Biodegradable particulate vector for transporting molecules having biological activity
|
|
US5283253A
(en)
*
|
1991-09-23 |
1994-02-01 |
Florida State University |
Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
|
|
US5200534A
(en)
*
|
1992-03-13 |
1993-04-06 |
University Of Florida |
Process for the preparation of taxol and 10-deacetyltaxol
|
|
US5521184A
(en)
*
|
1992-04-03 |
1996-05-28 |
Ciba-Geigy Corporation |
Pyrimidine derivatives and processes for the preparation thereof
|
|
US5780676A
(en)
*
|
1992-04-22 |
1998-07-14 |
Ligand Pharmaceuticals Incorporated |
Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
|
|
US5711968A
(en)
*
|
1994-07-25 |
1998-01-27 |
Alkermes Controlled Therapeutics, Inc. |
Composition and method for the controlled release of metal cation-stabilized interferon
|
|
US5686268A
(en)
*
|
1992-06-19 |
1997-11-11 |
Pfizer Inc. |
Fused proteins
|
|
US5294637A
(en)
*
|
1992-07-01 |
1994-03-15 |
Bristol-Myers Squibb Company |
Fluoro taxols
|
|
US5202448A
(en)
*
|
1992-08-14 |
1993-04-13 |
Napro Biotherapeutics, Inc. |
Processes of converting taxanes into baccatin III
|
|
JPH08501085A
(ja)
*
|
1992-08-26 |
1996-02-06 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
抗腫瘍剤としてのサイトカインｉｐ−１０の利用
|
|
FR2696458B1
(fr)
*
|
1992-10-05 |
1994-11-10 |
Rhone Poulenc Rorer Sa |
Procédé de préparation de dérivés du taxane.
|
|
US6214542B1
(en)
*
|
1992-10-20 |
2001-04-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Quantification of indicators of fibrosis
|
|
US5279949A
(en)
*
|
1992-12-07 |
1994-01-18 |
Board Of Trustees Operating Michigan State University |
Process for the isolation and purification of taxol and taxanes from Taxus spp
|
|
EP0707650B1
(en)
*
|
1993-06-21 |
2003-05-21 |
Genentech, Inc. |
Process for producing human relaxin
|
|
US5728377A
(en)
*
|
1993-07-20 |
1998-03-17 |
Board Of Regents, The University Of Texas System |
Methods and compositions incorporating IP-10
|
|
JP3220331B2
(ja)
*
|
1993-07-20 |
2001-10-22 |
エチコン・インコーポレーテツド |
非経口投与用の吸収性液体コポリマー類
|
|
US5426098A
(en)
*
|
1993-09-02 |
1995-06-20 |
Celtrix Pharmaceuticals, Inc. |
Increase in hematopoietic progenitor cells in peripheral blood by transforming growth factor beta
|
|
US5643575A
(en)
*
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5415869A
(en)
*
|
1993-11-12 |
1995-05-16 |
The Research Foundation Of State University Of New York |
Taxol formulation
|
|
EP0662515B1
(en)
*
|
1993-12-10 |
2000-11-15 |
Korea Institute Of Science And Technology |
Signal sequences for secretion of heterologous proteins from yeast
|
|
US5861499A
(en)
*
|
1994-02-10 |
1999-01-19 |
Imclone Systems Incorporated |
Nucleic acid molecules encoding the variable or hypervariable region of a monoclonal antibody that binds to an extracellular domain
|
|
US5536249A
(en)
*
|
1994-03-09 |
1996-07-16 |
Visionary Medical Products, Inc. |
Pen-type injector with a microprocessor and blood characteristic monitor
|
|
US5461031A
(en)
*
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
|
US5504188A
(en)
*
|
1994-06-16 |
1996-04-02 |
Eli Lilly And Company |
Preparation of stable zinc insulin analog crystals
|
|
US5484720A
(en)
*
|
1994-09-08 |
1996-01-16 |
Genentech, Inc. |
Methods for calcium phosphate transfection
|
|
US5547929A
(en)
*
|
1994-09-12 |
1996-08-20 |
Eli Lilly And Company |
Insulin analog formulations
|
|
US5693609A
(en)
*
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
|
US5770382A
(en)
*
|
1994-12-30 |
1998-06-23 |
Ligand Pharmaceuticals, Inc. |
Tricyclic retinoids, methods for their production and use
|
|
US5770378A
(en)
*
|
1994-12-30 |
1998-06-23 |
Ligand Pharmaceuticals, Inc. |
Tricyclic retinoids, methods for their production and use
|
|
US5770383A
(en)
*
|
1994-12-30 |
1998-06-23 |
Ligand Pharmaceuticals, Inc. |
Tricyclic retinoids, methods for their production and use
|
|
US6090822A
(en)
*
|
1995-03-03 |
2000-07-18 |
Margolin; Solomon B. |
Treatment of cytokine growth factor caused disorders
|
|
US5811395A
(en)
*
|
1995-06-07 |
1998-09-22 |
Medical University Of South Carolina |
Relaxin analogs and derivatives methods and uses thereof
|
|
US6020473A
(en)
*
|
1995-08-25 |
2000-02-01 |
Genentech, Inc. |
Nucleic acids encoding variants of vascular endothelial cell growth factor
|
|
US6066318A
(en)
*
|
1995-10-05 |
2000-05-23 |
G.D. Searle & Co. |
Multi-functional hematopoietic fusion proteins between sequence rearranged C-MPL receptor agonists and other hematopoietic factors
|
|
US6100071A
(en)
*
|
1996-05-07 |
2000-08-08 |
Genentech, Inc. |
Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
|
|
DE69736860T2
(de)
*
|
1996-09-24 |
2007-05-16 |
Merck & Co., Inc. |
Verbindungen zur hemmung der angiogenese durch gentherapie
|
|
BR9712283A
(pt)
*
|
1996-10-09 |
1999-08-31 |
Boehringer Mannheim Pharm Corp |
Método para inibir as cinases de proteìnas ativadas por tensão
|
|
ATE271063T1
(de)
*
|
1996-10-16 |
2004-07-15 |
Icn Pharmaceuticals |
Purin-l-nukleoside, deren analoga und verwendungen
|
|
AP1019A
(en)
*
|
1996-10-18 |
2001-10-16 |
Vertex Pharma |
Inhibitors of serinre proteases, particularly hepatitis C virus NS3 protease.
|
|
ZA984697B
(en)
*
|
1997-06-13 |
1999-12-01 |
Lilly Co Eli |
Stable insulin formulations.
|
|
TW517055B
(en)
*
|
1997-07-02 |
2003-01-11 |
Smithkline Beecham Corp |
Novel substituted imidazole compounds
|
|
NZ502358A
(en)
*
|
1997-07-18 |
2002-11-26 |
Infimed Therapeutics Inc |
Hydrogel composition comprising a biologically active substance combined with a macromer
|
|
US6168784B1
(en)
*
|
1997-09-03 |
2001-01-02 |
Gryphon Sciences |
N-terminal modifications of RANTES and methods of use
|
|
ZA9811070B
(en)
*
|
1997-12-08 |
2000-07-03 |
Genentech Inc |
Type I interferons.
|
|
EP1037995A1
(en)
*
|
1997-12-08 |
2000-09-27 |
Genentech, Inc. |
Human interferon-epsilon: a type 1 interferon
|
|
AR014621A1
(es)
*
|
1997-12-12 |
2001-03-28 |
Macromed Inc |
Un poli (etilenglicol) con forma de estrella, heterofuncional, biocompatible, metodo para su obtencion y metodo para conjugarlo con una proteina
|
|
US6387879B1
(en)
*
|
1997-12-15 |
2002-05-14 |
Dgi Biotechnologies, Inc. |
Compounds that bind growth to hormone receptor
|
|
US6423695B1
(en)
*
|
1998-01-13 |
2002-07-23 |
Ribapharm, Inc. |
Cytokine related treatments of disease
|
|
CA2317411C
(en)
*
|
1998-01-30 |
2005-06-28 |
Scios Inc. |
Controlled release delivery of peptide or protein
|
|
US5961495A
(en)
*
|
1998-02-20 |
1999-10-05 |
Becton, Dickinson And Company |
Medication delivery pen having a priming mechanism
|
|
US6221053B1
(en)
*
|
1998-02-20 |
2001-04-24 |
Becton, Dickinson And Company |
Multi-featured medication delivery pen
|
|
US6248095B1
(en)
*
|
1998-02-23 |
2001-06-19 |
Becton, Dickinson And Company |
Low-cost medication delivery pen
|
|
CN1548436A
(zh)
*
|
1998-05-22 |
2004-11-24 |
ʷ��˿�������ȳ�ķ����˾ |
新的2-烷基取代咪唑化合物
|
|
US6685933B1
(en)
*
|
1998-07-28 |
2004-02-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Interferon α hybrids
|
|
US6323180B1
(en)
*
|
1998-08-10 |
2001-11-27 |
Boehringer Ingelheim (Canada) Ltd |
Hepatitis C inhibitor tri-peptides
|
|
US6211144B1
(en)
*
|
1998-10-16 |
2001-04-03 |
Novo Nordisk A/S |
Stable concentrated insulin preparations for pulmonary delivery
|
|
IT1303736B1
(it)
*
|
1998-11-11 |
2001-02-23 |
San Raffaele Centro Fond |
Peptidi derivati da rantes con attivita' anti-hiv.
|
|
DE69919969T2
(de)
*
|
1998-12-17 |
2005-09-29 |
Applied Research Systems Ars Holding N.V. |
Humanes Wachstumshormon zur Stimulierung der Hämatopoese und der Immunrekonstitution nach hämatopoetischer Stammzelltransplantation beim Menschen
|
|
US6703225B1
(en)
*
|
1999-01-12 |
2004-03-09 |
Sumitomo Pharmaceuticals Company, Limited |
Interferon-α
|
|
PT1181036E
(pt)
*
|
1999-04-09 |
2008-10-03 |
Ortho Mcneil Pharm Inc |
Composições farmacêuticas de eritropoietina
|
|
US6492497B1
(en)
*
|
1999-04-30 |
2002-12-10 |
Cambridge Antibody Technology Limited |
Specific binding members for TGFbeta1
|
|
US6531122B1
(en)
*
|
1999-08-27 |
2003-03-11 |
Maxygen Aps |
Interferon-β variants and conjugates
|
|
US20040002474A1
(en)
*
|
1999-10-07 |
2004-01-01 |
Maxygen Inc. |
IFN-alpha homologues
|
|
US6586398B1
(en)
*
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
|
US6346269B1
(en)
*
|
2000-05-08 |
2002-02-12 |
Standard Chem. & Pharm. Co., Ltd. |
Method for preparing an oral formulation containing acid-sensitive drugs and oral formulation made thereby
|
|
US20010053764A1
(en)
*
|
2000-05-12 |
2001-12-20 |
Sims John E. |
Interleukin-1 inhibitors in the treatment of diseases
|
|
US6673580B2
(en)
*
|
2000-10-27 |
2004-01-06 |
Genentech, Inc. |
Identification and modification of immunodominant epitopes in polypeptides
|
|
WO2002081507A2
(en)
*
|
2001-04-06 |
2002-10-17 |
Maxygen Holdings Ltd. |
Interferon gamma polypeptide variants
|
|
US6958388B2
(en)
*
|
2001-04-06 |
2005-10-25 |
Maxygen, Aps |
Interferon gamma polypeptide variants
|
|
US20030073832A1
(en)
*
|
2001-04-10 |
2003-04-17 |
Havez Sophie Elisabeth |
Novel aminophenyl ketone derivatives
|
|
US6585398B1
(en)
*
|
2001-06-22 |
2003-07-01 |
Genlyte Thomas Group, Llc |
Post top deck light fixture
|
|
CA2477577A1
(en)
*
|
2002-03-12 |
2003-09-18 |
Maxygen Aps |
Interferon beta-like molecules for treatment of stroke
|
|
EP1549675B1
(en)
*
|
2002-08-31 |
2008-02-13 |
CJ Corp |
Glycosylated human interferon alpha isoform
|
|
DE60332358D1
(de)
*
|
2002-09-09 |
2010-06-10 |
Hanall Pharmaceutical Co Ltd |
Protease-resistente modifizierte interferon alpha polypeptide
|
|
KR100781666B1
(ko)
*
|
2004-11-02 |
2007-12-03 |
신영기 |
인간 인터페론-베타 변이체
|